Safety and efficacy of MORAb-202 in patients (pts) with platinum-resistant ovarian cancer (PROC): Results from the expansion part of a phase 1 trial

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: ee03ddfec5fd10a20755c6ae081919a90bdc4060
First added on: Feb 14, 2025